Goodwin Procter advised Apollo Intelligence on the deal. Apollo Intelligence announced its sale to Frazier Healthcare Partners. Apollo will continue to focus on elevating industry standards for […]
Frazier Healthcare Partners’ Acquisition of Apollo Intelligence
Future Plc’s Acquisition of WhoWhatWear
Holland & Knight advised Future plc on the deal while Goodwin Procter represented Clique Brands. Future plc (LSE: FUTR), the global platform for specialist media, announced its […]
Nuvig Therapeutics’ $47 Million Series A Financing
Goodwin advised Nuvig Therapeutics on the deal. Nuvig Therapeutics announced its $47 million Series A financing and the launch of the company to develop novel therapeutics that […]
Ontario Teachers’ Pension Plan’s Investment in VerSe Innovation
Goodwin advised Ontario Teachers’ Pension Plan on the deal. Ontario Teachers’ Pension Plan announced its investment in VerSe Innovation as part of VerSe Innovation’s US$ 805 million […]
Regeneron Pharmaceuticals’ Acquisition of Checkmate Pharmaceuticals
Wachtell, Lipton, Rosen & Katz advised Regeneron on the deal, while Goodwin represented Checkmate Pharmaceuticals. Fried Frank acted as counsel to Centerview Partners, financial advisor to […]
Thoma Bravo’s Acquisition of SailPoint Technologies Holdings
Goodwin Procter advised SailPoint Technologies Holdings, Inc. on the deal. SailPoint Technologies Holdings, Inc. (NYSE: SAIL) announced its definitive agreement to be acquired by Thoma Bravo. Under […]
Limelight Networks’ $300 Million Acquisition of Yahoo’s Edgecast
Goodwin Procter advised Limelight Networks on the deal. Paul, Weiss, Rifkind, Wharton & Garrison represented Edgecast, Inc. and funds managed by affiliates of Apollo in the […]
Cast & Crew’s Acquisition of Backstage Holdings
Latham & Watkins represented Cast & Crew in the transaction while Goodwin advised TA Associates and Backstage Holdings. Cast & Crew, a leading end-to-end cloud-based platform […]
Vista and Evergreen’s $16.5 Billion Acquisition of Citrix
Kirkland & Ellis and Kinstellar advised Vista, and Gibson, Dunn & Crutcher and Debevoise & Plimpton advised Evergreen. Goodwin Procter represented Citrix in the transaction. Wilson […]
OpenSea’s Acquisition of Dharma Labs
Latham & Watkins represented OpenSea, while Goodwin represented Dharma Labs in the transaction. OpenSea, an nonfungible token (NFT) marketplace, has announced that it is acquiring Dharma Labs. […]
Eluminex Biosciences’ Acquisition of Zuretinol Acetate Assets from Retinagenix
Goodwin Procter advised Eluminex Biosciences on the deal. Eluminex Biosciences (Suzhou) Limited (Eluminex) announced its acquisition of certain assets and the related global development and commercialization rights […]
Qilu Pharmaceutical’s Licensing Agreement and Partnership with Arbutus Biopharma Corporation
Goodwin Procter advised Qilu Pharmaceutical on the deal. Qilu Pharmaceutical, one of the leading pharmaceutical companies in China (“Qilu”), announced its exclusive licensing agreement and strategic partnership […]